Peter Lutwyche, PhDChief Technology Officer at Genevant Sciences Corporation
Dr. Lutwyche has responsibility for manufacturing, process development, quality control, quality assurance and project management for all Arbutus product candidates as well as supporting Arbutus’s collaborative partners as they advance products based on Arbutus technology. Dr. Lutwyche joined Arbutus from QLT Inc., where he was employed for ten years, most recently as Director, Pharmaceutical Development. During his tenure at QLT, Dr. Lutwyche contributed to the development and commercialization of the product Visudyne as well as leading manufacturing and chemistry efforts for numerous preclinical and clinical stage products. Prior to QLT, he was a research scientist at Inex Pharmaceuticals Corporation working with lipid-based formulations of nucleic acids and antibiotics. Dr. Lutwyche holds a Ph.D. in Chemistry from the University of British Columbia.